BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25379618)

  • 21. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
    Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
    Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis.
    Roulland S; Navarro JM; Grenot P; Milili M; Agopian J; Montpellier B; Gauduchon P; Lebailly P; Schiff C; Nadel B
    J Exp Med; 2006 Oct; 203(11):2425-31. PubMed ID: 17043145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does double-hit follicular lymphoma with translocations of MYC and BCL2 change the definition of transformation?
    Katsushima H; Fukuhara N; Konosu-Fukaya S; Himuro M; Kitawaki Y; Ichikawa S; Ishizawa K; Sasano H; Harigae H; Ichinohasama R
    Leuk Lymphoma; 2018 Mar; 59(3):758-762. PubMed ID: 28771060
    [No Abstract]   [Full Text] [Related]  

  • 24. In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).
    Aya-Bonilla C; Camilleri E; Haupt LM; Lea R; Gandhi MK; Griffiths LR
    BMC Genomics; 2014 May; 15(1):390. PubMed ID: 24885312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients.
    Geyer JT; Subramaniyam S; Jiang Y; Elemento O; Ferry JA; de Leval L; Nakashima MO; Liu YC; Martin P; Mathew S; Orazi A; Tam W
    Hum Pathol; 2015 Feb; 46(2):260-71. PubMed ID: 25529125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma.
    Bouska A; Zhang W; Gong Q; Iqbal J; Scuto A; Vose J; Ludvigsen M; Fu K; Weisenburger DD; Greiner TC; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Delabie J; Jaffe ES; Braziel RM; Connors JM; Wu CI; Staudt LM; D'Amore F; McKeithan TW; Chan WC
    Leukemia; 2017 Jan; 31(1):83-91. PubMed ID: 27389057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting transformation in follicular lymphoma.
    de Jong D; de Boer JP
    Leuk Lymphoma; 2009 Sep; 50(9):1406-11. PubMed ID: 19606378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transformation of indolent follicular lymphoma into diffuse large B-cell lymphoma - the molecular basis of "cancer aggressiveness".
    Kledus F; Filip D; Mráz M
    Klin Onkol; 2023; 36(4):353-363. PubMed ID: 37877527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantifying the role of aberrant somatic hypermutation in transformation of follicular lymphoma.
    Halldórsdóttir AM; Frühwirth M; Deutsch A; Aigelsreiter A; Beham-Schmid C; Agnarsson BA; Neumeister P; Richard Burack W
    Leuk Res; 2008 Jul; 32(7):1015-21. PubMed ID: 18180034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.
    Thompson MA; Edmonds MD; Liang S; McClintock-Treep S; Wang X; Li S; Eischen CM
    Hum Pathol; 2016 Apr; 50():118-26. PubMed ID: 26997445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential development of histiocytic sarcoma and diffuse large b-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: a divergent (bilineal) neoplastic transformation of an indolent B-cell lymphoma in a single individual.
    Wang E; Papalas J; Hutchinson CB; Kulbacki E; Huang Q; Sebastian S; Rehder C; Silbermins D; Moore J; Datto M
    Am J Surg Pathol; 2011 Mar; 35(3):457-63. PubMed ID: 21317718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma.
    Davies AJ; Lee AM; Taylor C; Clear AJ; Goff LK; Iqbal S; Cuthbert-Heavens D; Calaminici M; Norton AJ; Lister TA; Fitzgibbon J
    Leukemia; 2005 Aug; 19(8):1459-65. PubMed ID: 15902285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma.
    Hu X; Baytak E; Li J; Akman B; Okay K; Hu G; Scuto A; Zhang W; Küçük C
    Leuk Res; 2017 Mar; 54():30-38. PubMed ID: 28095352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations.
    Guo S; Chan JK; Iqbal J; McKeithan T; Fu K; Meng B; Pan Y; Cheuk W; Luo D; Wang R; Zhang W; Greiner TC; Chan WC
    Clin Cancer Res; 2014 Jun; 20(12):3078-86. PubMed ID: 24634383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma.
    Wrench D; Leighton P; Skibola CF; Conde L; Cazier JB; Matthews J; Iqbal S; Carlotti E; Bödör C; Montoto S; Calaminici M; Gribben JG; Lister TA; Fitzgibbon J
    Blood; 2011 Mar; 117(11):3147-50. PubMed ID: 21233317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microarray studies of prognostic stratification and transformation of follicular lymphomas.
    Sigal S; Ninette A; Rechavi G
    Best Pract Res Clin Haematol; 2005 Mar; 18(1):143-56. PubMed ID: 15694190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA signatures in subtypes of follicular lymphoma.
    Gebauer N; Gollub W; Stassek B; Bernard V; Rades D; Feller AC; Thorns C
    Anticancer Res; 2014 May; 34(5):2105-11. PubMed ID: 24778012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression.
    Guo Y; Karube K; Kawano R; Suzumiya J; Takeshita M; Kikuchi M; Huang GS; Li Q; Ohshima K
    Pathol Int; 2007 Mar; 57(3):148-52. PubMed ID: 17295647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature.
    Ichikawa K; Aritaka N; Ogura K; Hosone M; Ota Y; Sato E; Komatsu N; Hirano T
    Int J Clin Exp Pathol; 2015; 8(6):7559-64. PubMed ID: 26261669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular, cytogenetic, and immunophenotypic characterization of follicular lymphoma grade 3B; a separate entity or part of the spectrum of diffuse large B-cell lymphoma or follicular lymphoma?
    Bosga-Bouwer AG; van den Berg A; Haralambieva E; de Jong D; Boonstra R; Kluin P; van den Berg E; Poppema S
    Hum Pathol; 2006 May; 37(5):528-33. PubMed ID: 16647949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.